Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
TGA:5
Drug Approvals
AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial (349310)
- Product Name
- AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vial
- Approval Date
- Jan 28, 2022
TGA
LEDAGA chlormethine (as hydrochloride) 160 microgram/g topical gel tube (338551)
- Product Name
- LEDAGA chlormethine (as hydrochloride) 160 microgram/g topical gel tube
- Approval Date
- Jun 22, 2021
TGA
ALOXI palonosetron (as hydrochloride) 75 microgram/1.5mL solution for injection vial (281464)
- Product Name
- ALOXI palonosetron (as hydrochloride) 75 microgram/1.5mL solution for injection vial
- Approval Date
- Aug 22, 2017
TGA
AKYNZEO netupitant/palonosetron (as hydrochloride) 300 mg/500 mcg capsule blister pack (222237)
- Product Name
- AKYNZEO netupitant/palonosetron (as hydrochloride) 300 mg/500 mcg capsule blister pack
- Approval Date
- May 6, 2015
TGA
ALOXI palonosetron (as hydrochloride) 250 microgram/5mL solution for injection vial (114185)
- Product Name
- ALOXI palonosetron (as hydrochloride) 250 micrograms/5mL solution for injection vial
- Approval Date
- Jun 26, 2006
TGA
Clinical Trials
No trials found
News
No news found